How the plasma membrane is bent to accommodate clathrin-independent endocytosis remains uncertain. Recent studies suggest Shiga and cholera toxin induce membrane curvature required for their uptake into clathrin-independent carriers by binding and cross-linking multiple copies of their glycosphingolipid receptors on the plasma membrane. But it remains unclear if toxin-induced sphingolipid crosslinking provides sufficient mechanical force for deforming the plasma membrane, or if host cell factors also contribute to this process. To test this, we imaged the uptake of cholera toxin B-subunit into surface-derived tubular invaginations. We found that cholera toxin mutants that bind to only one glycosphingolipid receptor accumulated in tubules, and that toxin binding was entirely dispensable for membrane tubulations to form. Unexpectedly, the driving force for tubule extension was supplied by the combination of microtubules, dynein and dynactin,
Results

Assay for analysis of tubulation of the plasma membrane
To study mechanisms that participate in bending the plasma membrane during clathrinindependent endocytosis, we took advantage of a previously described assay that traps STxB and CTxB in surface attached tubules thought to correspond to stalled endocytic intermediates (18, 30) . Several conditions facilitate the growth of surface attached tubular invaginations containing fluorescently labeled toxins, including ATP depletion, actin disruption, cholesterol depletion and inhibition of dynamin. These conditions are thought to be permissive for tubule growth, but prevent tubule scission, leading to the accumulation of toxin within these structures.
CTxB accumulated in linear, microns-long tubules in ATP-depleted cells and/or when actin was either disrupted or stabilized ( Figures 1A-D and S1 ). Control experiments revealed that STxB and CTxB localized to the same tubules in cells incubated with both toxins, supporting the idea they are formed by a common mechanism ( Figure S1D ). We also found that the tubules were rapidly labeled by a second application of CTxB after they had formed, confirming that the tubules originated from the plasma membrane and were surface attached for the time course of these studies ( Figure S1E ). In cells treated with the dynamin inhibitor Dynasore, irregular branched networks of tubules were observed ( Figure 1E ), resembling those seen before in cells expressing a Dynamin1 K44A mutant (17) . These findings confirm that CTxB readily associates with membrane tubules under a variety of conditions that inhibit scission, thus allowing us to further study requirements for tubule formation.
Binding to a single GM1 is sufficient to support the association of cholera toxin with tubular invaginations
Current models propose compaction of glycosphingolipids by toxin binding plays an essential role in initiating membrane curvature and tubulating the membrane to form plasma membrane invaginations (18) . A mutant form of STxB lacking the Gb 3 binding site III demonstrated greatly reduced ability to drive tubule formation in cells, suggesting multiple glycosphingolipid binding sites enhance the ability of toxins to deform membranes (18) . To test if cholera toxin binding causes plasma membrane tubulations by compacting or reorienting multiple glycosphingolipids into a curved surface in a similar manner, we first studied a mixture of chimeric cholera toxins (CTx chimera ) that bind 0, 1 or 2 glycosphingolipid receptors (ganglioside GM 1 ) instead of the usual 5 (28) . Unexpectedly, the chimeric mutant toxins were readily observed in tubular invaginations in ATP-depleted cells, and the average number of invaginations per cell and length of the invaginations were similar for wild type and chimeric toxins ( Figure 1F -I). We next asked if a toxin with only a single GM 1 binding site (monovalent CTx) (29) can be directed to tubules. Strikingly, this monovalent CTx was localized within tubular invaginations as well ( Figure 1J -O), suggesting that toxin-induced crosslinking of GM 1 is dispensable for tubule formation.
Toxin binding is dispensable for tubule formation
The finding that extensive crosslinking of GM 1 is not required for tubules to form suggests that the elongated tubules containing CTx may be generated by machinery endogenous to the host cell. If so, cellular plasma membrane proteins should also be found in the tubular invaginations in the absence of bound toxin. To test this, we first screened several cell surface markers for co-localization with CTxB in tubular invaginations. Several cell surface proteins were found to extensively label tubular structures even in the absence of CTxB binding (Figures 2 and S2 ). As one example, the cytosolic plasma membrane-associated protein HRas (GFP-HRas) strongly localized to the tubular invaginations both in the presence of CTxB and independently of CTxB in response to ATP-depletion, actin disruption or actin stabilization (Figure 2A-F) . In ATP-depleted cells, a similar number of GFP-HRas positive tubules were found in the presence (18 ± 15, n = 26 cells) or absence (18 ± 11, n = 23 cells) of CTxB, suggesting they form by the same mechanism. Tubule formation was not stimulated by the GTPase activity of Ras, because a minimal membrane targeted form of GFP, GFP-HRas tail, also labeled tubules ( Figure 2G, H) . Thus, tubulation of the plasma membrane can occur in the absence of toxin-induced cross-linking of glycolipids, indicating that the driving force(s) for tubule extension can be generated by factors endogenous to the host.
An intact microtubule network is required for the formation of extended tubular invaginations
It is well known that microtubules and microtubule motors are capable of deforming membranes (32) (33) (34) . Such mechanisms are not currently thought to contribute to the early stages of endocytosis (32) . However, CTxB has previously been found to localize within microtubule-dependent tubular invaginations of intact BSC1 cells, suggesting a microtubuledependent process of toxin uptake (13) . Consistent with these findings, we noticed that the tubular invaginations containing CTxB in ATP-depleted cells were often directed toward the cell center in an orientation typifying the microtubule network (Figures 1F, J and 2A) and that the microtubule networks remained intact after ATP depletion ( Figure 3A) . Tubular invaginations containing CTxB were also often found aligned closely with taxol-stabilized microtubules ( Figure 3B , C).
When imaged over time (Movies S1 and S2), the tubules sometimes grew smoothly ( Figure  3D -F), but were often observed to pause and undergo bi-directional motions ( Figure 3G -I) and branching events ( Figure 3J ) characteristic of microtubule-dependent motions. We thus asked if the microtubule network was required for tubular invaginations to form. Remarkably, disruption of microtubules prior to CTxB binding led to a complete loss of tubular invaginations containing the toxin in ATP-depleted cells ( Figure 4A, C) . Microtubule disruption also inhibited the formation of tubules containing CTxB or monovalent CTx in cells subjected to dynamin inhibition, actin disruption or actin stabilization (Figure 4E , F; Figure S3A , B). Thus, the extended tubular invaginations are strongly microtubule dependent.
Microtubule plus end dynamics are not required for the growth of tubular invaginations
To elucidate how microtubules might support tubulation of the plasma membrane, we first considered a mechanism in which interactions between membranes and dynamic microtubules are mediated by plus-end binding proteins to drive endomembrane translocation (35) (36) (37) (38) (39) . To test this possibility, we monitored the plus-end binding protein GFP-EB3 (40) . In ATP-depleted cells, GFP-EB3 still labeled microtubules, but was no longer concentrated at their tips (Movie S3), indicating enrichment of plus-end binding proteins at microtubule ends cannot be required for tubule formation. Furthermore, pretreating cells with low doses of nocodazole (150 nM) to suppress microtubule plus-end dynamics (40) (41) (42) had no detectable effect on the number of ATP-depleted cells that contained CTxB-positive invaginations ( Figure 4B, D) . Dynamic microtubule growth thus cannot explain tubule extension.
Low levels of microtubule motor activity are retained in ATP-depleted cells
Another way microtubules could support the growth of invaginations would be through the activity of microtubule-based motors (32) (33) (34) 43) . Microtubule-based motility involves two classes of motor proteins, dynein and members of the kinesin family (44, 45) . Given that the tubular invaginations underwent preferential growth toward the center of the cell, where microtubule minus ends are located (Figure 1 , Movies S1 and S2), we hypothesized that the minus-end directed motor dynein might be involved.
Dynein is an ATPase (44) whose activity is expected to be attenuated in ATP-depleted conditions. We thus asked if dynein still functions as a motor in cells depleted of ATP by monitoring the intracellular movement of lysosomes labeled with mCherry-tagged LAMP1 (46) . Although strongly reduced compared to control cells, some long-range motions of lysosomes persisted in ATP-depleted cells ( Figure 5A -G) (Movie S4). These data imply that motor proteins remain active at low levels in ATP-depleted cells, consistent with dynein's known activity under low ATP conditions in vitro (47, 48) .
We also asked whether dynein is localized appropriately to assist with tubule extension. Due to incompatibility of fixation conditions required to preserve dynein staining and tubule morphology, we were unable to determine whether endogenous dynein was present on tubular invaginations. We therefore instead used a HeLa cell line stably expressing low levels of multifunctional green fluorescent protein (mfGFP)-tagged 74-kDa dynein intermediate chain (IC74) (49) to visualize both simultaneously. Some mfGFP-IC74 could be observed at the plasma membrane in ATP-depleted cells, and a few dynein intermediate chain-positive puncta co-localized with the tubular invaginations ( Figure S4 ). These findings further support the possibility that at least a small number of dyneins are localized correctly to facilitate plasma membrane tubulation under these conditions.
The ATPase activity of dynein and an intact dynactin complex are required for tubule extension
To test if dynein contributes to the formation of extended tubular plasma membrane invaginations, we used a small molecule inhibitor of dynein, ciliobrevin A (50). In the presence of ciliobrevin A, we observed impaired formation of tubular invaginations containing CTxB in ATP-depleted cells ( Figure 6A, B) . This result implicates dynein in the extension of tubular invaginations. To test this hypothesis in another way, we inhibited the function of dynactin, a complex required for dynein function (44, 51) . We perturbed dynactin by overexpressing either a GFP-tagged form of p50/dynamitin (51) ( Figure 6C ) or a dsRedtagged form of the dynein-binding portion of the dynactin subunit p150 Glued , CC1-dsRed (51) (Figure 6D, E) . Overexpression of either protein strongly inhibited the formation of tubular invaginations in response to ATP depletion ( Figure 6C -E). p50 expression also blocked extended branched tubules from forming in Dynasore-treated cells ( Figure S3E, F) . Thus, dynactin is required for tubulation of the membrane, further implicating dynein as a host cell factor that underlies tubule extension.
Bulk uptake of CTxB is unaffected by disruption of microtubules or the dynactin complex, suggesting the tubular carriers define a low capacity endocytic pathway Given our findings that microtubules, dynactin and dynein are required for plasma membrane tubulation, we wondered if they are also necessary for the uptake of CTxB. CTxB can be internalized by multiple mechanisms (12, 13) , including a high capacity pathway that involves morphologically distinct clathrin-independent carriers (16, 17) and tubular endocytic intermediates that contain CTxB (13) . Interestingly, we found that uptake of CTxB into ATP replete cells was unaffected by the expression of GFP-p50 ( Figure 7A , B) or pretreatment of cells with nocodazole ( Figure 7C, D) . Thus, the microtubuledependent pathway cannot be highly efficient or high capacity. However, these results do not exclude the possibility that uptake of toxin by plasma membrane tubules is physiologically relevant -as cholera toxin-induced toxicity is poorly correlated with overall levels of toxin internalization (13) . Indeed, we found that intact microtubules were required for full toxicity of CTx in polarized human intestinal epithelial T84 cells, as measured by an electrophysiological assay that monitors toxin-induced Cl -secretion (52) ( Figure 7E ). This is consistent with a role for microtubules in the uptake or trafficking of CT.
Discussion
Here, we show that microtubules, dynein and dynactin provide an important source of mechanical force that tubulates the plasma membrane during clathrin-independent endocytosis of CTxB. Interestingly, similar tubules were observed in the presence and absence of bound toxin, suggesting they demarcate an endogenous, toxin-independent pathway. Very recent evidence indicates microtubules and dynein are also involved in the clathrin-independent uptake of STxB via endophilin A2-containing tubules (53) . Formation of these endophilin A2-positive tubules is strongly induced by toxin binding (53) . Thus, the mechanism of dynein-and microtubule-dependent membrane tubulation that we describe here appears to be a general one utilized by multiple classes of clathrin-independent carriers, inclusive of both constitutive and cargo-induced pathways.
On the basis of our findings, we propose a model wherein dynein and dynactin can interact with the plasma membrane and adjacent microtubules to allow formation and extension of nascent endocytic tubules ( Figure 8 ). Dynein likely drives tubule extension by pulling the membrane along existing microtubules, albeit only slowly under conditions where ATP is limiting as in ATP-depleted cells. Other minus end directed motors, such as kinesins-14 might also contribute to these processes. By providing an internal pulling force that drives membrane curvature, motor-driven bending of the plasma membrane could facilitate recruitment of curvature-sensitive/generating proteins that help stabilize and elongate tubules (54, 55) . Pulling forces could also participate in other steps in clathrin-independent endocytosis. For example, they could help sort cargo into tubules in a curvature-dependent manner (56) (57) (58) , as well as contribute to the process of membrane scission (53, 59 ).
The exact mechanism by which dynein and dynactin bind the plasma membrane and how this process is regulated in clathrin-independent endocytosis remains to be determined. It could involve recruitment to sites of local membrane bending induced by endogenous cellular factors, similar to that previously described for recruitment of dynein by retromer (56) , or in the case of the toxins, by membrane bending at the site of toxin binding as discussed further below (18, 30, 53) . Caveolae could potentially serve as a preferential site for dynein/dynactin recruitment to the plasma membrane, as caveolin-1 has been observed in long, toxin-positive tubules under conditions that inhibit endocytosis (24, 60) .
The mechanism of attachment of dynein/dynactin to the plasma membrane may alternatively be related to those involved in positioning of the mitotic spindle (61) . This scenario seems less likely given that stable anchoring of dynein at the cell cortex is thought to facilitate microtubule-dependent pulling forces (62) . Interestingly however, microtubule-dependent plasma membrane invaginations have been reported to form in C. elegans embryos at cortical sites where spindle poles are tethered (63) . These invaginations are observed at low frequency in unperturbed embryos, but are more readily evident under conditions where the actomyosin cortex is weakened (63) . This suggests that cortical actin reorganization may represent a key event that determines whether microtubule-and dynein-dependent tubulation of the plasma membrane can occur. For example, cortical actin may normally act as a physical barrier between microtubules and the cell surface. Reorganization of cortical actin, either through endogenous processes or in response to actin perturbing agents (64) , may permit microtubules access to the plasma membrane, facilitating the formation of the extended tubular carriers into which endocytic cargo such as CTxB enters. Changes in cortical actin organization could also potentially decrease plasma membrane tension, favoring the formation of long invaginations by microtubule-dependent pulling. Actin dynamics may in turn ultimately also contribute to the tubule scission process that releases tubules from the plasma membrane (21,53).
Our findings also have important implications for our understanding of how glycosphingolipid-binding toxins such as cholera toxin and Shiga toxin manipulate cell membranes to facilitate their uptake and subsequent cellular intoxification. It is clear that CTx and STx binding to multiple copies of their glycosphingolipid receptors enhances their toxicity (18, 28, 29, 30, 65) and that toxins can induce membrane bending in vitro (18, 30) . Toxin binding can also initiate the recruitment of curvature-sensing proteins to the plasma membrane (53). However, cross-linking of membrane lipids is dispensable for both plasma membrane tubulation (this study) and CTx intoxication of host cells (28, 29) . While CTxB binding is not required for extended tubular invaginations to form, membrane reorganizations and local bending induced by the AB5 toxins binding to their sphingolipid receptors (18, 30) may function cooperatively with the microtubule-based mechanisms of membrane tubulation we propose here. Toxin binding may for example contribute to the induction or stabilization of membrane curvature (53) or favor sorting of the glycosphingolipid-toxin complex into curved structures (66) . Indeed, we observed a slight preference of wild type CTxB for sorting into tubules compared to mutant toxins containing only 1 or 2 lipid GM 1 binding sites. Scission of toxin-containing tubules may also depend on cooperative actions of curvature generating proteins and microtubule-based motors (53) . Under physiological conditions, STxB and CTxB could also potentially regulate cellular machinery that controls membrane curvature, either by signaling-based mechanisms (67) or by directly influencing microtubule dynamics (68) . Still, the cross-linking of membrane glycosphingolipids by toxin is not absolutely required for sorting into tubules or internalization. Our results implicate other mechanisms of membrane tubulation in this pathway, one of which we propose is facilitated by microtubules and the microtubule motor dynein.
Materials and Methods
Cells and reagents
COS-7 and HeLa cells were acquired from ATCC (Manassas, VA). Stable RFP-α-tubulin expressing HeLa cells were a gift from Paul Chang (M.I.T.). HeLa cells stably expressing multifunctional GFP (mfGFP)-tagged 74 kDa dynein intermediate chain (IC74) were kindly provided by Takashi Murayama (Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan). T84 cells were cultured as previously described (52) . COS-7 cells were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (Life Technologies) at 37°C and 5% CO 2 . HeLa cells were maintained in Roswell Park Memorial Institute medium (RPMI) containing 10% fetal bovine serum at 37°C and 5% CO 2 . Media for RFP-α-tubulin HeLa cells additionally contained G418 (Corning), and hygromycin (400 μg/mL) (Invitrogen) was added to media for the IC74 cells. Cells were plated on coverslips or into MatTek chambers (MatTek Corporation) 2 days prior to experiments. Transient transfections were performed 24 h prior to imaging using FuGENE 6 as per manufacturer instructions (Roche Diagnostics).
Alexa488-CTxB and Alexa555-CTxB were obtained from Invitrogen. CTx chimera was generated as previously described (28) . Monovalent CTx was made essentially as described (29) . Briefly, an E. coli expression strain containing three plasmids encoding native CTA, CTB-G33D (non-binding mutant) and C-terminally GS-H6-tagged wt-CTB was induced with 0.0005% L-arabinose and 400 μM IPTG and grown overnight at 30°C. Each subunit is secreted to the periplasm where holotoxins with mixed CTB pentamers assemble from a random assortment of G33D mutant and GS-H6-tagged wt CTB monomers with CTA. This mixture of assembled holotoxins and free B pentamers containing from 0 to 5 GS-H6 tagged B subunits (native binding sites) was purified from a cell extract by Talon affinity chromatography, and separated into individual species by three rounds of ion-exchange chromatography. Free pentamers were first removed by binding to a cationic resin (HS20); the mixture of holotoxins eluting in the unbound fraction was then bound to an HQ20 anion exchange column, and individual species were eluted with a 0-1 M NaCl gradient, peak fractions were pooled, concentrated and repurified by anion exchange. Densitometry of protein bands separated by SDS-PAGE showed the expected ratio of 1 A and 1 tagged wt B subunit to 4 native-sized (G33D) B subunits. Purified holotoxins were stored at 4°C in 50 mM Tris-HCl, pH 8.0. Before labeling, several preparations of single binding site holotoxin were pooled, concentrated and buffer-exchanged into PBS, pH 7.5 by ultrafiltration using an Amicon Ultra-4 (Millipore) 10 K cutoff centrifugal filter.
Alexa568-labeled monovalent CTx was prepared by reacting Alexa568-succinimidyl ester (Invitrogen) to 300 μg toxin chimera (29) in 100 mM sodium bicarbonate buffer pH 8.3 for 1 h under stirring at room temperature and purified using provided size exclusion chromatography resin. Alexa568-labeled wild type CTxB was prepared as above using recombinant B-subunit purified from periplasmic E. coli extracts. Alexa 488-STxB and Cy3-STxB along with a plasmid for Gb 3 transferase (69,70) were gifts from Ludger Johannes (Institut Curie).
Plasmids encoding EGFP-HRas, EGFP-HRas-tail (consisting of GFP fused to the C-terminal 10 amino acid residues of HRas), and GFP-Fyn were provided by Mark Philips (NYU School of Medicine) (71); GFP-EB3 (40) was a gift from Anna Akhmanova (Utrecht University); and CC1-dsRed and GFP-p50 (72) were gifts from Trina Schroer (Johns Hopkins). LYFPGT46 (referred to as YFP-GT46) was as previously described (73, 74) . MyrPalm-mCFP was obtained from Roger Tsien (75) .
A plasmid encoding mCherry-LAMP1 was generated by standard techniques by fusing the mammalian expression plasmid for mCherry to DNA encoding rat lysosomal membrane glycoprotein 1 (LAMP1; NM_012857; gift from George Patterson, NIH). A rabbit anticaveolin-1 antibody was obtained from BD Biosciences. A mouse anti-transferrin receptor antibody was purchased from Life Technologies. A rabbit anti-GFP antibody was obtained from Abcam. An anti-Myc (9B11) mouse monoclonal antibody was from Cell Signaling. Fluorescently labeled secondary antibodies were from Jackson ImmunoResearch and Life Technologies. D(+)glucose, sodium azide, 2-deoxyglucose, bovine serum albumin (BSA), trichloroacetic acid, Nocodazole (NZ), Dynasore, Latrunculin A, methyl β-cyclodextrin and ciliobrevin A (HPI-4) were purchased from Sigma Aldrich. Taxol was from Alexis Biochemical. HEPES and TAE buffers were purchased from Mediatech, Inc.. Alexa546-dextran was from Life Technologies. Jasplakinolide and Alexa647-transferrin were obtained from Invitrogen.
Confocal microscopy
Confocal microscopy was carried out on a Zeiss LSM 510 confocal microscope (Carl Zeiss MicroImaging, Inc.) using a 40X 1.4 NA Zeiss Plan-Neofluar oil immersion objective or 100X 1.4 NA Zeiss Plan-Apochromat oil immersion objective. Images were collected using 1 Airy unit confocal slices unless otherwise indicated. Cells were maintained in media supplemented with 25 mM HEPES and any indicated drugs as described above for live-cell imaging experiments. Cells were maintained at 37°C using a stage heater and objective heater during imaging. EGFP and Alexa488 were excited using the 488 nm line of a 40 mW Argon laser. YFP was excited using the 514 nm line of the Argon laser. Alexa546, Alexa555, Alexa568, Cy3, RFP and mCherry were excited at 543 nm using a HeNe laser. Alexa647 was excited at 647 nm using a HeNe laser. Fluorescence emission was detected using filter sets provided by the manufacturer. For presentation purposes, images were exported in tiff format and brightness and contrast were adjusted using ImageJ or Fiji (76) .
ATP depletion
ATP depletion was performed by pre-incubating cells at 37°C and 5% CO 2 for 15 min in ATP depletion medium, composed of glucose-free DMEM containing 50 mM 2-deoxy-Dglucose, 0.02% sodium azide, 25 mM HEPES, and 1 mg/mL BSA as described in (77) . Control cells were incubated in ATP control medium (composed of glucose-free DMEM supplemented with 50 mM D-(+)-glucose, 25 mM HEPES, and 1 mg/mL BSA). Cells were rinsed twice, incubated for 5 min at room temperature with CTxB (100 or 500 nM), STxB (99 nM), CTx chimera (500 nM) or monovalent CTx (400 or 800 nM), rinsed twice, then imaged live at 37°C in either ATP depletion or control media. ATP depletion also induces the formation of abundant actin-rich membrane protrusions (78), so ATP-depleted cells were always imaged in 3-dimensions by confocal microscopy to definitively identify invaginations ( Figure S1 ). For some experiments, cells were pretreated with Jasplakinolide (250 nM) for 30 min prior to ATP depletion, then imaged in the continued presence of both Jasplakinolide and ATP depletion medium.
Quantification of cellular ATP levels
ATP depletion was verified to decrease ATP levels to <5% of control values using the commercially available ENLITEN ® ATP assay kit (Promega). For this assay, COS-7 cells were split into 12 well plates. After 2 days the medium was removed and some cells were incubated directly in 500 μL ATP-extraction solution [1% TCA in Tris-Acetate-EDTA (TAE) buffer] to collect baseline ATP readings. The remaining cells were rinsed twice with ATP depletion media and incubated at 37°C and 5% CO 2 . At the indicated times after the initiation of ATP depletion, the depletion media was replaced with 500 μL ATP-extraction solution. Cells were incubated in ATP-extraction solution for 30 min at RT, as described before (79) . Aliquots of the cell extract were then moved to 96 well plates and diluted tenfold in TAE buffer. Reaction reagent containing luciferase was added to each well and the chemiluminescence was read on a Synergy H4 Hybrid Multi-Mode Microplate Reader (BioTek).
Actin disruption
To disrupt actin, cells were first washed with imaging buffer, incubated for 5 min in 1 μM Alexa546-CTxB in imaging buffer, and washed again. Actin depolymerization was then performed by incubating the cells at 37°C for 5 min in imaging buffer containing 1 μM Latrunculin A. Control cells were incubated in imaging buffer containing 0.1% DMSO. Cells were maintained in their respective buffer during imaging and all imaging was performed within 30 min of treatment. Where indicated, cells were preincubated with 5 μg/mL NZ for 15 min on ice, followed by a 1 h incubation at 37°C prior to Latrunculin A treatment and CTxB labeling, then imaged live in the continued presence of both Latrunculin A and NZ.
Actin stabilization
Cell culture media was replaced with complete imaging buffer containing 250 nM Jasplakinolide or DMSO and incubated at 37°C and 5% CO 2 for 30 min. Cells were then labeled with 100 nM Alexa-labeled CTxB for 5 min at RT in complete imaging buffer containing 250 nM Jasplakinolide or DMSO. Cells were rinsed and imaged in complete imaging buffer containing 250 nM Jasplakinolide or DMSO. Where indicated, cells were ATP depleted following Jasplakinolide treatment as described above. In some experiments, cells were preincubated with 5 μg/mL NZ for 15 min on ice followed by a 1 h incubation at 37°C prior to Jasplakinolide treatment and CTxB labeling, then imaged live in the continued presence of both Jasplakinolide and NZ.
Dynamin inhibition
Dynamin 2 was inhibited using the small molecule inhibitor, Dynasore (80) . Cell culture media was replaced with DMEM supplemented with 25μM HEPES and either 80 μM Dynasore or DMSO. Cells were incubated in Dynasore or DMSO at 37°C and 5% CO 2 for 30 min. Cells were then labeled with either 100 nM Alexa568-CTxB or 400-800 nM Alexa568 monovalent CTx for 5 min at RT, rinsed and imaged in DMEM supplemented with 25 μM HEPES and either 80 μM Dynasore or DMSO. Where indicated, cells were preincubated with 5 μg/mL NZ for 15 min on ice followed by a 1 h incubation at 37°C prior to Dynasore treatment and CTxB or monovalent CTx labeling, then imaged live in the continued presence of both Dynasore and NZ. In other experiments, cells were transfected with GFP or GFP-p50 prior to Dynasore treatment and toxin labeling as described above, then imaged live.
Analysis of surface accessibility of tubules
ATP depleted COS-7 were labeled with 25 nM Alexa555-CTxB and placed on the stage at 37°C. A highly concentrated dose of Alexa488-CTxB was added to bring the final Alexa488-CTxB concentration in the imaging buffer to 50 nM while continuously imaging.
Immunofluorescence labeling
For immunostaining of caveolin-1 and transferrin receptor, cells grown in MatTek dishes were subjected to ATP depletion and labeled with CTxB as described above. After CTxB labeling they were incubated for 30 min 37°C and 5% CO 2 in the continued presence of the ATP depletion media. They were then fixed at 37°C with 4% PFA/0.2% glutaraldehyde for 15 min. After rinsing several times they were blocked in PBS containing 10% FBS and 0.1% saponin for 15 min and then labeled with transferrin receptor or caveolin-1 antibodies for 30 min. They were again washed and then labeled with secondary antibody for 30 min. After several additional washes they were imaged.
In IC74 cells, immunolabeling of the tagged dynein intermediate chain subunit was performed using an anti-myc antibody in order to amplify the fluorescence signal. For these experiments, cells grown on coverslips were either ATP depleted for 15 min or left untreated. They were then rinsed twice and incubated for 5 min at room temperature with 100 nM Alexa488-CTxB or Alexa555-CTxB. The cells were then rinsed twice and fixed at 37°C for 15 min in pre-warmed 4% PFA/0.2% glutaraldehyde. Post fixation, the cells were quenched by three rinses in 100 mM glycine in PBS. Permeabilization and blocking for 60 min at RT was performed in blocking buffer composed of 0.1% TX-100 in PBS containing 5% glycine and 5% normal goat or donkey serum. Cells were incubated with rabbit anti-myc antibody for 2 h at RT. After rinsing in PBS coverslips were incubated for 1 h in a 1:200 dilution of fluorescently-conjugated secondary antibodies, and mounted using ProLong Gold (Invitrogen, Carlsbad, CA).
Microtubule stabilization
HeLa cells expressing RFP-α-tubulin were incubated with imaging buffer containing 1 μM taxol for 4 h at 37°C. They were then rinsed twice with ATP depletion media containing 1 μM taxol, incubated at 37°C for 15 min, labeled with 100 nM Alexa-labeled CTxB for 5 min at RT, rinsed and imaged in ATP depletion media containing 1 μM taxol.
Suppression of microtubule plus end dynamics
Cells were incubated with imaging buffer containing 150 nM NZ (40) (41) (42) or DMSO at 37°C for 5 min. The media was then replaced with ATP depletion media supplemented with 150 nM NZ or DMSO and incubated at 37°C for 15 min. Cells were labeled with 100 nM Alexalabeled CTxB for 5 min at RT, rinsed and imaged in ATP depletion media containing 150 nM NZ or DMSO.
Microtubule disruption
To disrupt microtubules, cells were incubated with imaging buffer (phenol red-free DMEM, 10% BSA, 25 mM HEPES, and 1 mg/mL BSA) containing 5 μg/mL (16.7 μM) NZ (81, 82) or DMSO on ice for 15 min. Cells were then shifted to 37°C for 1 h and subjected to further drug treatments and CTx or CTxB labeling as indicated above. Cells were imaged in the continued presence of either NZ or DMSO. The efficacy of microtubule disruption was confirmed by visualizing the distribution of tubulin in control experiments.
Analysis of fluid phase and transferrin uptake in ATP-depleted cells
Control experiments were carried out to verify the efficacy of ATP depletion by testing its effects on fluid phase and transferrin uptake ( Figure S1 ). For the fluid phase uptake experiments, COS-7 cells were preincubated in ATP control media or ATP depletion media for 15 min. They were then labeled with 100 nM Alexa488-CTxB (to mark the position of cells) and Alexa546-Dextran (1 mg/mL) for 20 min at 37°C, rinsed 10 times with the respective media and imaged live. To measure transferrin uptake in ATP-depleted cells, cells were serum starved for 1 h prior to incubation in ATP control media or ATP depletion media for 15 min. They were then labeled with 100 nM Alexa488-CTxB (to mark the position of cells) and 25 μg/mL Alexa647 transferrin for 20 min at 37°C, rinsed 5 times with respective media, and imaged live.
Inhibition of dynein motor activity
In control experiments, we defined conditions in which ciliobrevin A inhibited the dyneinbased delivery of CTxB to the perinuclear region in cells with physiological levels of ATP ( Figure S3C, D) . To generate ciliobrevin A dose dependence curves, ciliobrevin A was diluted in DMSO and stocks were produced by serial dilution in DMEM + 10% fetal bovine serum. Cells were incubated in medium containing ciliobrevin A or DMSO at 37°C for 1 h. They were then labeled with 100 nM Alexa-labeled CTxB in ciliobrevin A or DMSO containing media for 5 min at RT, rinsed and either fixed immediately or shifted to 37°C and 5% CO 2 for 30 min prior to fixation with 3.4% PFA at RT for 15 min. Samples were mounted in ProLong Gold (Invitrogen, Carlsbad, CA) and fields of cells were imaged and image analysis performed as indicated below.
For experiments examining the effects of ciliobrevin A on tubule formation, cell culture media was replaced with imaging buffer containing 500 μM ciliobrevin A or DMSO and incubated at 37°C and 5% CO 2 for 1 h. Cells were rinsed twice with ATP depletion or control media containing ciliobrevin A or DMSO and incubated at 37°C and 5% CO 2 for 15 min. Cells were labeled with 100 nM Alexa-labeled CTxB for 5 min at RT, rinsed and imaged in ATP depletion or control media containing ciliobrevin A or DMSO. Care was taken to protect ciliobrevin-A from light throughout experiment.
Analysis of fluid phase uptake in cells expressing GFP-p50
COS-7 cells transiently expressing EGFP or EGFP-p50 were loaded with Alexa-546 dextran (1 mg/mL) in 100 μL of serum free imaging buffer and incubated at 37°C for 20 min, rinsed with imaging buffer 10 times and imaged live. Images were collected using a 1 Airy unit confocal slice under identical imaging conditions for cells expressing EGFP and EGFP-p50.
Analysis of transferrin and CTxB uptake in cells expressing GFP-p50
COS-7 cells plated on cover slips were transfected with EGFP or GFP-p50. To quantify the cellular uptake of CTxB, cells were rinsed with cold imaging buffer and labeled with 100 nM A555-CTxB for 5 min on ice. For quantification of transferrin uptake, cells were serum starved using DMEM containing 25 mM HEPES for 1 h at 37°C and 5% CO 2 . Serum starved cells were then rinsed with cold DMEM supplemented with 10% FBS and 25 mM HEPES and labeled with 5 μg/mL Alexa568-transferrin for 5 min on ice. Cells were rinsed with imaging buffer and shifted to 37°C and 5% CO 2 for 20 min. Acid stripping was performed on ice by incubating cells with 2 mL of 100 mM glycine, pH 2.0, for 5 min and then with HBSS, pH 7.4, for 5 min. Acid-stripped samples were subsequently incubated with 37°C HBSS, pH 7.4, for 10 s to promote release of remaining surface-bound toxin or transferrin (83) . This process was repeated 3 times. Cells were fixed in 3.4% PFA at room temperature for 15 min and rinsed with 1x PBS. Cells were labeled with an anti-GFP primary antibody and an Alexa488 secondary antibody. Samples were mounted in ProLong Gold. Cells were imaged at 1x zoom and multiple fields were collected using a 1 Airy unit confocal slice for CTxB and a 2 Airy unit slice for transferrin. Experiments were performed at least three times.
Analysis of fluid phase uptake in NZ-treated cells
COS-7 cells were transiently transfected with EGFP (to mark the position of cells) the day before the experiment. The next day, cells were pre-chilled on ice in serum free imaging buffer for 5 min, then incubated with serum free imaging buffer containing 5 μg/mL (16.7 μM) NZ or DMSO on ice for 15 min. Cells were then shifted to 37°C for 1 h. They were then labeled with Alexa546 dextran (1 mg/mL) for 20 min at 37°C in the continued presence of NZ or DMSO, rinsed 10 times with the respective media and imaged live. Images were collected using a 1 Airy unit slice under identical imaging conditions for the NZ and DMSO-treated samples.
Analysis of transferrin and CTxB uptake in NZ-treated cells
COS-7 cells were transiently transfected with EGFP (to mark the position of cells) the day before the experiment. The next day, cells were pre-chilled on ice in serum free imaging buffer for 5 min, then incubated with serum free imaging buffer containing 5 μg/mL (16.7 μM) NZ or DMSO on ice for 15 min. Cells were then shifted to 37°C for 1 h. Cells were then labeled with either CTxB or transferrin exactly as described above except that NZ or DMSO were included in all labeling and washing steps. Acid stripping and further processing of cells was performed exactly as described above.
Electrophysiology
Measurements of short circuit currents (Isc) and resistance (R) were performed on confluent monolayers of human intestinal T84 cells grown on 0.33 cm 2 filters, as previously described (52) . Monolayers were treated with 5 μg/mL nocodazole or DMSO for 30 min on ice followed by further incubation for 30 min at 37°C prior to addition of 20 nM cholera toxin.
Image analysis
To quantify the percentage of a population of ATP-depleted cells containing invaginations, full field (512 × 512) z-stacks of fields of cells were taken at 1.7× zoom on a 40× objective, with line averaging of 4 and optimal overlay in z-direction. z-Stacks were collected consecutively for 50 min after labeling with toxin. Cells were then scored by hand as displaying or not displaying invaginations. For cells expressing a plasmid, that is CC1-dsRed, the cells were scored in the CTxB channel with the experimentalist blind to which cells were expressing the plasmid and which were not.
To determine the number and length of invaginations z-sections were taken of individual ATP-depleted cells consecutively for 50 min after labeling with toxin. The JFilament plugin (Dimitrios Vavylonis and Xiaolei Huang; Lehigh University) for ImageJ was used to trace individual invaginations in 2D. The automated snake tracking feature was used to align the snakes with the invaginations. Tracings were examined and corrected by hand. Kymographs were produced using the MultipleKymograph plugin for ImageJ.
To quantify the effects of ATP depletion, NZ treatment and GFP-p50 expression on the uptake of endocytic cargo, outlines of cells were made in the GFP or CTxB channel using ImageJ. The average fluorescence intensity in the endocytic cargo channel was then recorded from the same regions. Background fluorescence was measured from regions devoid of cells. After subtracting background, the data were normalized to 100% of control values.
For lysosomal tracking experiments, particle detection was performed using a customwritten MATLAB algorithm (available upon request) and tracking was performed using utrack 2.0 software (http://lccb.hms.harvard.edu/software.html) (84) . Both programs were run using MATLAB 7.11.0 (Mathworks).
The ciliobrevin A dose dependence curve was generated by collecting full field (512 × 512) 16 bit images using a 40x objective with line averaging of 8. ROIs were then drawn around the perinuclear space, flat membrane regions and background in ImageJ. Perinuclear and membrane per pixel fluorescence were corrected for background fluorescence and then divided to produce a perinuclear to membrane ratio per cell.
Statistical analysis
All experiments were performed at least twice and most were carried out three or more times. Chi-square tests were performed using Excel (Microsoft), and Student t-tests were performed using Excel or OriginPro 8.6 (OriginLab).
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